SI2640697T1 - Spojine 4-substituiran-3-fenilsulfanilmetil-biciklo(3.1.0)heksana kot antagonisti mglur 2/3 - Google Patents

Spojine 4-substituiran-3-fenilsulfanilmetil-biciklo(3.1.0)heksana kot antagonisti mglur 2/3

Info

Publication number
SI2640697T1
SI2640697T1 SI201131304T SI201131304T SI2640697T1 SI 2640697 T1 SI2640697 T1 SI 2640697T1 SI 201131304 T SI201131304 T SI 201131304T SI 201131304 T SI201131304 T SI 201131304T SI 2640697 T1 SI2640697 T1 SI 2640697T1
Authority
SI
Slovenia
Prior art keywords
phenylsulfanylmethyl
mglur
bicyclo
antagonists
substituted
Prior art date
Application number
SI201131304T
Other languages
English (en)
Inventor
Stephon Cornell Smith
Renhua Li
Charles Howard Mitch
Tatiana Natali Vetman
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45099188&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2640697(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of SI2640697T1 publication Critical patent/SI2640697T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/18All rings being cycloaliphatic the ring system containing six carbon atoms
SI201131304T 2010-11-18 2011-11-15 Spojine 4-substituiran-3-fenilsulfanilmetil-biciklo(3.1.0)heksana kot antagonisti mglur 2/3 SI2640697T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41512110P 2010-11-18 2010-11-18
EP11791692.4A EP2640697B1 (en) 2010-11-18 2011-11-15 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists
PCT/US2011/060730 WO2012068067A1 (en) 2010-11-18 2011-11-15 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists

Publications (1)

Publication Number Publication Date
SI2640697T1 true SI2640697T1 (sl) 2017-11-30

Family

ID=45099188

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201131304T SI2640697T1 (sl) 2010-11-18 2011-11-15 Spojine 4-substituiran-3-fenilsulfanilmetil-biciklo(3.1.0)heksana kot antagonisti mglur 2/3

Country Status (36)

Country Link
US (1) US8629169B2 (sl)
EP (1) EP2640697B1 (sl)
JP (1) JP5877847B2 (sl)
KR (2) KR20150140876A (sl)
CN (1) CN103228625B (sl)
AR (1) AR083845A1 (sl)
AU (1) AU2011329076B2 (sl)
BR (1) BR112013012118A2 (sl)
CA (1) CA2818116C (sl)
CL (1) CL2013001345A1 (sl)
CO (1) CO6761385A2 (sl)
CR (1) CR20130178A (sl)
DK (1) DK2640697T3 (sl)
DO (1) DOP2013000099A (sl)
EA (1) EA021724B1 (sl)
EC (1) ECSP13012629A (sl)
ES (1) ES2650139T3 (sl)
GT (1) GT201300126A (sl)
HR (1) HRP20171649T1 (sl)
HU (1) HUE037457T2 (sl)
IL (1) IL225843A (sl)
LT (1) LT2640697T (sl)
MA (1) MA34663B1 (sl)
MX (1) MX339973B (sl)
NO (1) NO2640697T3 (sl)
NZ (1) NZ609816A (sl)
PE (1) PE20140997A1 (sl)
PL (1) PL2640697T3 (sl)
PT (1) PT2640697T (sl)
RS (1) RS56535B1 (sl)
SG (1) SG189959A1 (sl)
SI (1) SI2640697T1 (sl)
TW (1) TWI520935B (sl)
UA (1) UA110039C2 (sl)
WO (1) WO2012068067A1 (sl)
ZA (1) ZA201302918B (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2978B1 (en) * 2009-12-21 2016-03-15 ايلي ليلي اند كومباني MGLU2 aids
EP3000814A1 (en) 2014-09-26 2016-03-30 Domain Therapeutics Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors
DK3445743T3 (da) 2016-04-18 2021-10-18 Taisho Pharmaceutical Co Ltd Prodrug af aminosyrederivat
JP2020506895A (ja) 2017-01-17 2020-03-05 ボード オブ レジェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System インドールアミン2,3−ジオキシゲナーゼおよび/またはトリプトファンジオキシゲナーゼの阻害剤として有用な化合物
US11046649B2 (en) 2018-07-17 2021-06-29 Board Of Regents, The University Of Texas System Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0669928B2 (ja) 1987-10-06 1994-09-07 宇部興産株式会社 光重合性歯科材料
JP2589812B2 (ja) 1989-07-05 1997-03-12 松下電器産業株式会社 スチームアイロン
EA000894B1 (ru) * 1995-11-16 2000-06-26 Эли Лилли Энд Компани Замещенные бициклогексанкарбоновые кислоты и их производные в качестве антагонистов рецептора возбуждающих аминокислот, способ их получения и применение
ZA969485B (en) 1995-11-16 1998-05-12 Lilly Co Eli Excitatory amino acid receptor antagonists.
ZA983930B (en) * 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
EP1064256B1 (en) * 1998-03-17 2004-08-04 Pfizer Products Inc. Bicyclo [2.2.1] heptanes and related compounds
GB9815542D0 (en) 1998-07-17 1998-09-16 Lilly Co Eli Bicyclohexane derivatives
CH694053A5 (de) 1998-09-03 2004-06-30 Hoffmann La Roche Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten.
WO2002068380A1 (en) * 2001-02-22 2002-09-06 Eli Lilly And Company Synthetic excitatory amino acids
AU2002359923B2 (en) 2001-12-27 2007-12-20 Taisho Pharmaceutical Co., Ltd. 6-fluorobicyclo[3.1.0]hexane derivatives
PT1517915E (pt) * 2002-06-11 2009-04-09 Lilly Co Eli Pró-drogas de amino ácidos de excitação
NZ580554A (en) * 2003-06-26 2011-01-28 Taisho Pharmaceutical Co Ltd 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative
JP2007063129A (ja) 2003-06-26 2007-03-15 Taisho Pharmaceut Co Ltd 2−アミノ−3−アルコキシビシクロ[3.1.0]ヘキサン誘導体
WO2005000790A1 (ja) * 2003-06-26 2005-01-06 Taisho Pharmaceutical Co., Ltd. 2-アミノビシクロ[3.1.0]ヘキサン-2,6-ジカルボン酸誘導体
JO2978B1 (en) * 2009-12-21 2016-03-15 ايلي ليلي اند كومباني MGLU2 aids

Also Published As

Publication number Publication date
CO6761385A2 (es) 2013-09-30
MA34663B1 (fr) 2013-11-02
DOP2013000099A (es) 2013-08-15
NO2640697T3 (sl) 2018-02-17
SG189959A1 (en) 2013-06-28
CR20130178A (es) 2013-07-09
WO2012068067A1 (en) 2012-05-24
TW201307271A (zh) 2013-02-16
TWI520935B (zh) 2016-02-11
KR20130101094A (ko) 2013-09-12
EA201390498A1 (ru) 2013-07-30
ZA201302918B (en) 2014-10-29
AU2011329076B2 (en) 2015-03-12
GT201300126A (es) 2014-02-27
IL225843A (en) 2015-05-31
JP2014505664A (ja) 2014-03-06
CA2818116A1 (en) 2012-05-24
RS56535B1 (sr) 2018-02-28
MX339973B (es) 2016-06-20
UA110039C2 (xx) 2015-11-10
CN103228625B (zh) 2014-12-03
AU2011329076A1 (en) 2013-05-02
CA2818116C (en) 2016-04-05
NZ609816A (en) 2014-12-24
HUE037457T2 (hu) 2018-08-28
EA021724B1 (ru) 2015-08-31
JP5877847B2 (ja) 2016-03-08
PT2640697T (pt) 2017-12-11
PL2640697T3 (pl) 2018-02-28
PE20140997A1 (es) 2014-08-25
EP2640697A1 (en) 2013-09-25
US8629169B2 (en) 2014-01-14
KR20150140876A (ko) 2015-12-16
LT2640697T (lt) 2018-01-10
HRP20171649T1 (hr) 2017-12-15
CL2013001345A1 (es) 2013-11-15
ES2650139T3 (es) 2018-01-17
CN103228625A (zh) 2013-07-31
AR083845A1 (es) 2013-03-27
IL225843A0 (en) 2013-06-27
US20120129902A1 (en) 2012-05-24
MX2013005622A (es) 2013-07-05
EP2640697B1 (en) 2017-09-20
ECSP13012629A (es) 2013-07-31
DK2640697T3 (en) 2017-10-23
BR112013012118A2 (pt) 2016-09-27

Similar Documents

Publication Publication Date Title
AP3391A (en) 2-Amino-4-arylthiazole compounds as TROA1 antagonists
IL225926A (en) Boronate compounds, preparations containing them and their uses
HK1174494A1 (en) Oil formulations comprising cylcopropene compounds
EP2606021A4 (en) 1,5-diphenyl-penta-1,4-dien-3-one compounds
AP2012006330A0 (en) Compounds as bradykinin B1 antagonists.
MY165626A (en) 1,2,4,-triazolone derivative
ZA201302918B (en) 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists
IL225440A0 (en) Compounds of cyclohexane derivatives, preparations containing them and their uses
GB201011831D0 (en) New compounds 5
GB201012359D0 (en) Invention 6.5.10
IL212235A (en) Component of inspiration
GB201009801D0 (en) Compounds 950
GB201000655D0 (en) New compounds 2
GB201015621D0 (en) Invention 30.08.10
GB201003296D0 (en) Acorn 1
GB201017331D0 (en) F.p.1
GB201012790D0 (en) Novel compounds 1
GB201012788D0 (en) Novel compounds 11
GB201004661D0 (en) 7.6.09
GB201009803D0 (en) Compounds 814
GB201009178D0 (en) New compounds 2
GB201009180D0 (en) New compounds 1
GB201000653D0 (en) New compounds 3
GB201021030D0 (en) gm 10
GB201112794D0 (en) Compactable footwear